Next Generation SARS-CoV-2 Test Measures Response to COVID-19 Vaccine and Neutralizing Antibody Levels in 10 Minutes
The second generation version of a rapid neutralizing antibody test for COVID-19 will not only show if the users have responded to their COVID-19 vaccine but also perform a semi-quantitative analysis of their neutralizing antibody levels in a single test. More...13 Oct 2021
Study Examines Proteins in Saliva to Predict COVID-19 Severity Risk in Children with Help of AI Model
A team of researchers is conducting a study to look at the relationship between proteins called cytokines in saliva and COVID-19 infection to help predict the severity of infection with the help of an artificial intelligence (AI) model. More...13 Oct 2021
CT Values Should Not Be Used to Assess Performance of SARS-CoV-2 PCR Tests or Triage COVID-19 Patients, Finds Study
A novel study has shown that coronavirus test cycle threshold (Ct) values should not be used to assess the performance of coronavirus tests or to triage COVID-19 patients. More...13 Oct 2021
Merck and Ridgeback Request FDA Emergency Use Authorization for First-Ever COVID-19 Antiviral Pill
Merck (Kenilworth, NJ, USA) and Ridgeback Biotherapeutics (Miami, FL, USA) have submitted an Emergency Use Authorization (EUA) application to the US Food and Drug Administration (FDA) for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. More...12 Oct 2021
Innovative Device That Allows Two COVID-19 Patients to Be Ventilated by Single Machine to Help End Worldwide Ventilator Shortage
A prototype device that allows two patients to be ventilated by a single machine could help solve the critical shortage of lifesaving ventilators seen around the world throughout the COVID-19 pandemic. More...
11 Oct 2021
Samsung Biologics and Enzolytics to Jointly Develop and Manufacture Anti-SARS-CoV-2 Monoclonal Antibody Therapies
Samsung Biologics (Incheon, Korea), a contract development and manufacturing organization, and Enzolytics Inc. (Plano, TX, USA), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, have entered into a strategic CDMO partnership agreement for the development and manufacturing of anti-HIV and anti-SARS-CoV-2 monoclonal antibody therapies. More...11 Oct 2021
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
LED Examination Lamp
Clarity 50 LED
New
Digital Radiographic System
OMNERA 300M
In Other News
New Stool-Based Assay Detects SARS-CoV-2 Genetic Material in Donor Stool Using RT-PCR
New Low-Cost COVID-19 Ventilator Could Resolve Mechanical Ventilators Shortage in Developing Countries
Blood Test for Combined Measurements of WBCs and Biomarkers Can Predict COVID-19 Severity
ECMO Life Support Offers Sickest COVID-19 Patients Slimmer Chance of Survival than Once Thought
Merck and Ridgeback’s Experimental Oral COVID-19 Antiviral Halves Risk of Hospitalization or Death
Shaoxing Andisi’s Closed Suction Catheters Reduce Risk of Cross Infection and Enable Easier, Quicker Suction
Study Showing Differing COVID-19 Antibody Profiles Among Vaccinated and Naturally Infected Individuals Presented at AACC 2021
Study Reveals Varying Antibody Responses and Adverse Reactions Among Recipients of Different COVID-19 Vaccines
New Rapid Test That Identifies Deteriorating COVID-19 Patients with Greater Accuracy than Existing Tests Presented at AACC 2021
New Blood Test for Occupational Stress Identifies Healthcare Professionals Burned out from COVID-19 Pandemic
Machine Learning Tools for COVID-19 Patient Screening Discussed at AACC 2021
MeMed Displays Disruptive Technology Award Finalist COVID-19 Severity Test at AACC 2021
EKG of Hospitalized COVID-19 Patients Can Predict Worsening Health and Death, Finds Study
Researchers Discover “Ultra-Potent” Monoclonal Antibody against Multiple SARS-CoV-2 Variants
New Algorithm Identifies Vaccinated Groups at Highest Risk of COVID-19 Hospitalization and Death
Artificial Intelligence (AI) Tool Predicts Oxygen Need of Hospitalized COVID-19 Patients Anywhere in the World
Ultrapotent Bispecific Antibodies That Can Simultaneously Bind to Two Different Antigens Neutralize SARS-CoV-2 Variants
Novel Ultrasound Scoring System Provides Accurate COVID-19 Diagnosis and Prognosis in Less Than 10 Minutes
World’s First COVID-19 Drug Based on Human Immunoglobulin Developed from Plasma of Recovered Patients
Low-Cost, Portable Ventilator Based on Intelligent 3D-Printed Origami Technology Could Improve COVID-19 Treatment
Novel Concept of Immunologic Resilience Can Accurately Predict Which COVID-19 Patients Will Advance to Severe Disease
Study Combining Brain MRI Findings and Latest RNA Sequencing Technology to Identify Drugs for Preventing Post-COVID Cognitive Impairment
Point-of-Care Ultrasound Predicts Clinical Outcomes in Patients with COVID-19
